In the BioHarmony Drug Report Database

"Preview" Icon

Natamycin

Natacyn (natamycin) is a small molecule pharmaceutical. Natamycin was first approved as Natacyn on 1982-01-01. It is used to treat aspergillosis, bacterial infections, blastomycosis, blepharitis, and candidiasis amongst others in the USA.

 

Trade Name

 

Natacyn
 

Common Name

 

natamycin
 

ChEMBL ID

 

CHEMBL1200656
 

Indication

 

aspergillosis, bacterial infections, blastomycosis, blepharitis, candidiasis, coccidioidomycosis, conjunctivitis, cryptococcosis, fungal eye infections, histoplasmosis, keratitis, microsporidiosis, protozoan infections, sporotrichosis, trichomonas vaginitis
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Natamycin structure rendering